|
|||||
|
|
Regression of pulmonary MALT lymphoma after treatment with rituximab |
|
| Authors: | Chong Elise A Svoboda Jakub Cherian Sindhu Andreadis Charalambos Downs Lisa H Zhuang Hongming Alavi Abass Tsai Donald E Schuster Stephen J |
| Affiliation: | a Hematology-Oncology Division, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvaniab Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvaniac Center for Functional Imaging, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania |
| Abstract: | We describe a patient with extranodal (pulmonary) marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) who was refractory to treatment with cytotoxic chemotherapy. After a single four-week course of rituximab she had significant regression of pulmonary lesions and remains progression free 19 months after finishing her treatment. This case report demonstrates the potential efficacy of rituximab as a single therapeutic agent in patients with pulmonary MALT lymphoma. |
| Keywords: | Rituximab non-Hodgkin's lymphoma MALT marginal zone lymphoma |
| 本文献已被 InformaWorld PubMed 等数据库收录！ | |